Continuous Bladder Irrigation Devices Market size was more than USD 1.5 billion in 2026 and is set to grow at a 4.47% CAGR between 2027 and 2036, reaching USD 2.32 billion by 2036. The industry revenue for 2027 is assessed at USD 1.56 billion.
Growing volumes of urological procedures will drive the continuous bladder irrigation devices market by increasing the need for reliable postoperative management of the urinary tract. Continuous irrigation is commonly used after selected procedures to help prevent clot formation and maintain catheter patency when bleeding or debris could obstruct urine flow. As hospitals perform more prostate, bladder, and other urological interventions, demand for integrated irrigation systems that enable controlled fluid delivery and drainage is increasing within postoperative care pathways.
An aging population will boost the continuous bladder irrigation devices market as age-related urological conditions, including benign prostatic hyperplasia, become more prevalent and contribute to greater demand for specialized urinary care. Patients undergoing procedures for prostate-related obstruction or other urinary complications may require continuous irrigation during recovery to maintain drainage and reduce the risk of catheter blockage. Increasing need for urological management among older adults is consequently supporting the use of dedicated irrigation systems in hospital and postoperative settings.
Expansion of hospital urology departments and improvements in procedural infrastructure will propel the continuous bladder irrigation devices market by increasing access to specialized interventions requiring postoperative bladder management. Modern operating rooms, recovery units, catheterization facilities, and dedicated urological care pathways allow hospitals to perform procedures under more standardized conditions and incorporate appropriate irrigation systems into routine workflows. Greater availability of trained clinical personnel and specialized equipment also supports consistent use of continuous irrigation during recovery and monitoring.
| Growth Driver Assessment Framework | |||||
| Growth Driver | Impact On CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising urological surgeries increasing demand for postoperative bladder irrigation systems | 2.00% | High | North America | High | Near Term |
| Growing geriatric population and BPH prevalence driving continuous urinary management needs | 1.80% | Moderate | Global | High | Mid Term |
| Expansion of hospital-based urology care infrastructure improving procedural adoption rates | 1.50% | Moderate | Asia Pacific, North America | Medium | Mid Term |
North America dominated the continuous bladder irrigation devices market in 2026, with a 33.74% share, reflecting the region's advanced hospital infrastructure and established use of specialized urological care technologies. Demand is supported by the prevalence of procedures requiring postoperative bladder irrigation, particularly within well-developed surgical and inpatient care settings. Strong clinical awareness, established infection-control practices, and the availability of sophisticated fluid management equipment also contribute to sustained adoption. Asia Pacific is projected to experience the fastest growth as healthcare systems expand their capacity for urological and surgical treatment, while rising hospital investment improves access to specialized medical devices. Increasing patient volumes, greater awareness of postoperative bladder management, and modernization of healthcare facilities are creating favorable conditions for broader use of continuous bladder irrigation systems.
Continuous bladder irrigation devices in the United States are widely integrated into post-operative urology workflows, particularly after TURP and hematuria management procedures. In the U.S., hospitals and ambulatory surgery centers emphasize automated flow control and closed-system designs to reduce catheter blockage risk and improve monitoring during acute urological care.
Japan’s demand for continuous bladder irrigation devices is influenced by an aging male population with higher incidence of prostate-related procedures and urinary retention management. In Japan, hospitals prioritize low-maintenance irrigation systems that reduce nursing workload while maintaining stable post-operative bladder clearance in acute care wards.
South Korea’s tertiary hospitals increasingly adopt continuous bladder irrigation devices in specialized urology departments, where post-surgical monitoring and rapid recovery pathways are emphasized. In South Korea, clinicians prefer devices with automated flow regulation and safety features to support efficient management of hematuria and post-operative bladder irrigation.
Germany’s use of continuous bladder irrigation devices is shaped by structured hospital urology protocols, where consistent post-surgical drainage management is prioritized. In Germany, inpatient departments emphasize closed-system irrigation and precise fluid control to minimize complications following prostate and bladder procedures, aligned with clinical guidelines and nursing standardization.
France’s public hospital system relies on continuous bladder irrigation devices for standardized post-operative urology care, particularly following prostate surgery and hematuria treatment. In France, procurement decisions are influenced by reimbursement structures and hospital tender systems, prioritizing reliable devices for consistent inpatient irrigation performance.
Italy’s continuous bladder irrigation device usage is concentrated in post-surgical urology recovery within hospital wards, particularly following prostate and bladder procedures. In Italy, clinicians emphasize practical systems that support nursing staff in maintaining catheter patency and reducing complications across public and private healthcare facilities.
Hospitals dominated the continuous bladder irrigation devices market, accounting for a 55.8% share in 2026, owing to the high concentration of urological procedures and postoperative care within hospital settings. Continuous bladder irrigation is frequently required for patients undergoing procedures or treatment involving urinary obstruction, bleeding, or clot formation, creating consistent demand for specialized irrigation systems. Hospitals also benefit from established nursing infrastructure, close patient monitoring, and access to urological specialists, which support the routine use of these devices in acute and postoperative care.
Long term care facilities are expected to be the fastest-growing end-use segment, supported by the increasing need for ongoing urinary care among patients requiring extended medical supervision. As long-term care populations often include individuals with chronic urological conditions, limited mobility, or complex post-treatment needs, continuous bladder management can become an important component of patient care. Greater emphasis on preventing urinary complications, improving patient comfort, and providing consistent catheter management is encouraging wider adoption of bladder irrigation solutions in these facilities.
The foley 3-way catheters segment held the largest share of 59.22% in 2026 within the continuous bladder irrigation devices market, reflecting their central role in delivering irrigation fluid while simultaneously supporting urine drainage. Their integrated design makes them particularly suitable for continuous bladder irrigation procedures where reliable fluid inflow, drainage, and catheter placement are required. Established clinical familiarity, broad use in postoperative urological care, and compatibility with established irrigation workflows continue to support their leading position.
Accessories are anticipated to be the fastest-growing product segment as healthcare providers increasingly seek complete and efficient systems for continuous bladder irrigation procedures. Irrigation tubing, drainage components, connectors, collection systems, and related accessories are essential for maintaining fluid flow and supporting safe procedural operation. Rising attention to infection prevention, workflow efficiency, and reliable device compatibility is encouraging demand for high-quality supporting components alongside primary catheter systems.
| Report Segmentation | |||
| Segment | Sub-Segment | Largest Segment | Fastest Growing Segment |
|---|---|---|---|
| End-use | Long Term Care Facilities, Hospitals, Others | Hospitals | Long Term Care Facilities |
| Product | Foley 3-Way Catheters, Accessories, Irrigation Bags | Foley 3-Way Catheters | Accessories |
1. Teleflex Incorporated (United States)
2. Becton Dickinson and Company (United States)
3. Coloplast A/S (Denmark)
4. Baxter International Inc. (United States)
5. Bactiguard Holding AB (Sweden)
6. Vogt Medical Vertrieb GmbH (Germany)
7. Angiplast Pvt. Ltd. (India)
8. Sterimed Group (France)
9. Advin Health Care (India)
10. AdvaCare Pharma (United States)
The continuous bladder irrigation devices market is progressing through the introduction of user-friendly systems designed to improve procedural efficiency and patient management in clinical settings. Manufacturers are prioritizing ergonomic device designs, simplified fluid management systems, and enhanced safety features to strengthen market competitiveness. Increased attention toward workflow optimization and improved healthcare outcomes continues to influence innovation trends across the market.